Sedaxylan 20 mg/ml contains the short acting alpha-2 agonist xylazine and is licensed for I/V administration.
It is also licensed for I/M administration in cattle; it has zero milk withdrawal and short one day meat withdrawal and sedation occurs in cattle within two minutes I/V and five to 10 minutes I/M.
Sedaxylan 20 mg/ml joins Dechra’s Nerfasin vet 100 mg/ml solution in the company’s anaesthesia and sedation range. Nerfasin vet also contains xylazine and is licensed for I/V administration for sedation and premedication prior to general anaesthesia in horses and cattle.
Alana McGlade, national sales manager at Dechra, said: “Dechra offers a comprehensive range of anaesthesia and sedation products allowing vets to customise protocols to the individual animal.
"Sedaxylan 20mg/ml and Nerfasin vet 100 mg/ml solution provide vets with flexible and convenient dosing options.”
Both Sedaxylan 20 mg/ml and Nerfasin vet 100 mg/ml are available in 25ml vials.
For more information, talk to your Dechra territory sales manager.
www.dechra.co.uk.
The centres have cutting-edge facilities, including high-tech audio-visual equipment with ceiling-mounted cameras to relay demonstrations, phantom models for abdominal ultrasound training and advanced simulators for practicing echocardiography.
The courses will be taught mainly by clinicians from across the IVC Evidensia network,
IVC says the centres will deliver 20,000 hours of CPD for its staff this year, and it aims to make its training available to the broader veterinary community towards the end of 2025.
Daniella Dos Santos, Director of Professional Culture at IVC Evidensia, said: “These centres will allow us to provide tailored training, whether you’re just starting your career or you’re looking to develop new skills and techniques.
"The training will help us deliver exceptional care for pets and their owners by ensuring our colleagues and eventually the wider profession continue to grow and develop their expertise.”
The RCVS has announced the steps it will be taking in response to the Standards Committee's review of 24/7 emergency care.
Whilst the College has stopped short of making home visits entirely discretionary, it has confirmed that with regards to 24/7 emergency care overall:
This follows RCVS Council's agreement in principle on recommendations that flowed from the Standards Committee's comprehensive review of 24/7 emergency care. The review was triggered by a number of issues, including the profession's response to the Chikosi Disciplinary Hearing of June 2013.
The College says the recommendations were developed out of a detailed process of evidence gathering, which included 656 pages of views submitted to the College, 2,801 signatures to a petition on home visits, a three-day select-committee-style hearing where representatives from 15 organisations and a further 10 individuals gave their views, a snapshot of responses from 1,062 vets taking part in the RCVS Survey of the Professions, and an online survey of 1,250 animal owners.
Council praised the work, which had been carried out under the guidance of Standards Committee Chair Clare Tapsfield-Wright, and agreed that draft changes to the supporting guidance to the Code of Professional Conduct should be refined and agreed by the Standards Committee and published over the next couple of months.
Clare said: "This process was not carried out as a typical consultation, with proposals being issued for consideration: we really wanted to be open to the views of the profession and the public from the start.
"We found that the profession did not wish to remove the 24/7 requirement, but there was a lot of frustration and concern, particularly around safety, home visits, who should be seen, outsourcing and contingency planning.
"The Standards Committee looked in detail at all of these issues and I am delighted to have Council's support for the general direction of our proposals. We will now review some changes to the wording of the new guidance, to improve clarity, and publish it as soon as possible."
President Neil Smith said: "I am delighted with the way this process has been carried out. No doubt the outcome will not please everyone, but these changes are based on robust evidence.
"The approach taken by the Standards Committee forms a useful model that could be adapted to address other such issues that we may face in the future."
The presentation given to Council on 5 June can be downloaded from the RCVS website at https://www.rcvs.org.uk/news-and-events/news/council-agrees-new-emphasis-for-24-7-guidance/ .
Ian Arundale (pictured right) was appointed as the new Chair of the DC following an application process from within existing Disciplinary Committee members, with the final interview panel consisting of Amanda Boag (President at the time), Ian Green (current DC Chair) and Miran Uddin (an independent barrister who works in regulatory law). Ian begins his role as chair in late October.
Ian is Deputy Chief Constable of Cleveland Police in the north east of England and was a police officer for 32 years serving in South Wales, West Mercia and Dyfed-Powys Police Forces. He currently provides expert witness services to inquests, courts and public inquiries. Ian has worked internationally and has assisted police forces and organisations in the USA, India, the Far East and New Zealand. In addition to his work with the RCVS, Ian is also the Chairperson of the Audit Committee for the City of Cardiff Council and is a board member of the International Law Enforcement Forum (ILEF).
Ian said: "I am pleased to have been selected as DC Chair and am looking forward to chairing the committee. The role of the DC is crucial to ensuring the RCVS protects and upholds the high standards of the UK veterinary professions, and I am humbled to be in a position to support this important function."
Dr Martin Whiting has been appointed as the new Vice Chair for the DC. Dr Whiting qualified as a veterinary surgeon from the Royal Veterinary College (RVC) in 2006. Following a few years in practice, he returned to academia to complete a Masters in Medical Law and Ethics and a PhD in the public interest in veterinary professional regulation. Martin was appointed as Lecturer in Veterinary Ethics and Law at the RVC in 2013 and became an RCVS and European Specialist in Animal Welfare, Ethics and Law. In 2017, Martin moved to the Home Office to work with the Animals in Science Committee and is currently the Head of Operations for the Animals in Science Regulation Unit.
Dr Bradley Viner has been appointed as the new Chair of the RCVS PIC and began his role on 1 July 2019.
Bradley was appointed through an independent selection process led by an external HR consultancy, with RCVS Council ratifying the final appointments. Bradley replaces Andrew Ash, who chaired the PIC from July 2015 up until Bradley’s appointment.
Bradley established his own small animal practice in Pinner, Middlesex, which then grew to a group of five practices in north-west London. In 2017 he sold his practices to the Linnaeus Group and now works for them as Group Clinical Quality Lead across all their sites. He was made a Fellow of the Royal College of Veterinary Surgeons in 2017 for Meritorious Contributions to Clinical Practice. Bradley was an elected member of RCVS Council between 2005 and 2017, including four years as RCVS Treasurer and one year as RCVS President in 2015-16.
Bradley said: "I was delighted to have been selected as Chair of this Statutory Committee as I feel it is one of the most important interfaces between the College, the profession and the public. It has a vital role to play in protecting animal welfare and the reputation of the profession, but I am well aware that fear of disciplinary proceedings can be very stressful to those involved. I undertake to continually strive to work to find a balance that ensures the Committee maintains a well-regulated profession acting in the public interest but also makes every effort to avoid causing unnecessary stress on members that are subject to its proceedings."
More information about the RCVS concerns investigation and disciplinary processes can be found at www.rcvs.org.uk/concerns.
Mr Chalkley faced three charges against him. The first was that he failed to identify some or all of the animals tested with Intradermal Comparative Tuberculin (ICT) tests at the farm.
The second charge was that Mr Chalkley had certified that he had carried out ICT tests on 279 animals at the farm and recorded the results on the accompanying paperwork but had, in fact, not adequately identified some or all of the 279 animals and had fabricated the skin thickness measurements recorded for some of them.
In addition, the charge alleged that Mr Chalkley’s conduct was dishonest, misleading and risked undermining government testing procedures designed to promote public health.
The third charge was that between June 2011 and September 2018, Mr Chalkley received payment of approximately £20,000 for ICT tests when, as a result of his conduct in relation to ICT tests at the farm, he was not entitled to such payment.
At the outset of the hearing Mr Chalkley admitted the first charge, that he had not adequately identified some of the animals.
On the third day of the hearing, during his evidence to the Committee, he admitted that his certification of the ICT testing was therefore misleading.
He denied the rest of the charges including that his conduct had been dishonest and that it had risked undermining government testing procedures designed to promote public health.
In considering the charges against Mr Chalkley, the Committee heard that discrepancies regarding the tests that were carried out on the farm in March 2018 were originally raised by the Animal and Plant Health Agency (APHA), on whose behalf Mr Chalkley carried out ICT testing in his capacity as an Official Veterinarian.
When Mr Chalkley gave evidence during the hearing, he explained that he had taken over TB testing for the farm in 2008 and that working conditions on the farm had been difficult throughout the whole period 2008 to 2018. He stated that due to the harsh weather conditions of early 2018, TB testing was difficult, and that the farmer needed to complete the test by March 2018 to avoid a financial penalty.
Mr Chalkley explained that one of the reasons for there being limited time available for him to carry out the test within the time required by the farmer was that he was due to provide veterinary cover at the Cheltenham races the following week and he was unable to find anyone else to cover the tests. Mr Chalkley also explained that during the tests on 5 and 8 March there had been limited farmhands available to assist in processing the cattle through the tests.
In the course of being asked questions by counsel for the RCVS, Mr Chalkley accepted that he had failed to identify some 45% of the animals he had injected on 5 March 2018 and had, in respect of each of the skin thickness measurements for those animals, randomly chosen a figure that he believed would be appropriate based on the breed, age and sex of the animal.
The APHA guidelines state that specific measurements should be made and recorded for each individual animal using callipers. Mr Chalkley said that he could not remember seeing the “pop-up” declaration which appeared when submitting the results to the APHA online and had never read it. He stated that he was not aware that he was making a declaration. However, he accepted that as an Official Veterinarian he was confirming that he had carried out the test properly. While he agreed that he knew that the test contained inaccuracies, he did not accept that he was being dishonest when he submitted the results.
Having considered all the evidence put forward by the RCVS and Mr Chalkley in his own defence, the Committee found that Mr Chalkley had acted dishonestly in deliberately choosing not to take the measurements on 5 March and had instead submitted fabricated alternatives, and so risked undermining public health by failing to carry out his duties as an OV.
The Committee also concluded that Mr Chalkley had been acting dishonestly, as he knew that he was submitting the test results as if they were the authentic outcome of a properly conducted test when in reality, they were no such thing.
The Committee did not accept Mr Chalkley’s evidence that he was unaware of the declaration which accompanied the submission of the test outcome. The Committee therefore found both the first and second charges proved.
In respect of the third charge the Committee found that this was not proven noting that the RCVS had not disproved Mr Chalkley’s explanation regarding his reasons for returning the £20,000 in fees he had received for carrying out TB testing at the farm from the APHA since 2011.
The Committee then considered whether the first two charges, both of which had been found proven, amounted to serious professional misconduct.
Ian Arundale, chairing the Committee and speaking on its behalf, said: “The Committee was prepared to accept that the respondent considered the risk arising from his actions as negligible. Nonetheless, in the Committee’s assessment a real risk existed due to the respondent’s actions and it was precisely the risk which the authorised testing procedure was designed to negate. The simple fact is the respondent could not be sure that each animal he assessed on 8 March 2018 had also been seen by him on 5 March 2018.
“However, the wider point with which the Committee was concerned related to the importance of any member of the profession or public being able to rely absolutely on the integrity of veterinary certification. Those parts of the Code and supporting guidance [concerning certification]… were unequivocal. It was very difficult to conceive of circumstances in which it could ever be justifiable to certify the outcome of a test which had not, in fact, been conducted in a way which was demonstrably valid and reliable. Such conduct was bound to be regarded as disgraceful by members of the profession and the general public.
“Honesty is the bedrock of appropriate certification and the Code and Guidance for the Disciplinary Committee is also unequivocal. Dishonesty in professional practice is always an extremely serious matter and the respondent’s responsibilities in the discharge of his functions as an Official Veterinarian were clear. On this occasion those responsibilities had been compromised.
“For these reasons, the Committee has come to the conclusion that the respondent’s conduct in relation to the facts found proved was disgraceful conduct in a professional respect.”
The Committee then went on to consider the sanction for Mr Chalkley.
The Committee heard oral evidence in mitigation, including from a former colleague who had worked with him in practice since 2006, as well as receiving a large number of written testimonials from various sources that attested to his honesty, integrity, willingness to help others, and charitable work in support of animal welfare.
Mr Chalkley’s counsel, in mitigation, highlighted his long and previously unblemished career, and characterised the conduct as an inexcusable but explicable error of judgement that was entirely isolated and out-of-character. Mr Chalkley’s counsel added that he had not done anything that he thought was seriously wrong, and there was no evidence that any harm had been done and that any risk to public health was not serious.
The Committee accepted that the conduct was isolated and out-of-character and that, furthermore, Mr Chalkley had made early and frank admissions to the APHA and that he had displayed a degree of insight, although the Committee was less confident that he truly understood the seriousness of the potential consequences of his dishonest conduct.
The Committee took into account the aggravating factors, including Mr Chalkley’s breach of trust of his position as an OV, the undermining of the integrity of veterinary certification, dishonesty and the potential public health impacts of his conduct.
Ian Arundale added: “The Committee considered that, having regard to the mitigating features which it had identified, a suspension order would be sufficient to send to the profession and the public a clear signal about the importance to be attached to accurate certification. The Committee considered that in the particular circumstances of this case, a period of three months suspension would be sufficient to achieve this objective.”
The full findings for the case can be found at: www.rcvs.org.uk/disciplinary
The company says the masterclass will equip veterinary surgeons with an understanding of how TPLO fits into the range of treatments for one of the commonest causes of serious hindlimb lameness in the adult dog: cranial cruciate ligament failure.
The course will take place on 13 and 14 September at Improve’s HQ, Alexandra House, Swindon, and will be led by Dr Steve Butterworth, MA VetMB CertVR DSAO MRCVS and RCVS Specialist in Small Animal Surgery (Orthopaedics).
Improve’s Veterinary Operations Manager Juliet Pope MRCVS, said: "We are delighted to offer this new masterclass, created for a maximum of ten delegates to ensure true one-to-one tutoring, and we thank the team at Freelance Surgical for supporting its development.
"The combination of lectures and practical sessions led by Steve Butterworth will revise relevant surgical anatomy to enable delegates to undertake TPLO procedures with confidence. We are particularly pleased to be able to offer radiography as an integral part of the course so that delegates can see the results of their new surgical skills before taking them back to their clinics."
Norbrook has verified that the pH of certain batches has increased over time and is out of specification.
This issue impacts the following batches:
A spokesperson said: "There has been no increased risk to animal safety identified but we take quality extremely seriously so we initiated a voluntary recall. We have informed all of the competent authorities and we are working with our distributor to advise immediate quarantine of any remaining inventory."
If you have any questions concerning the recall, contact Ms. Anita Vanderlaan Tel: +44 (0)28 3026 4435, Email: anita.vanderlaan@norbrook.co.uk
Ficoxil contains the active ingredient firocoxib, an NSAID from the coxib class, known for its analgesic, anti-inflammatory, and antipyretic properties.
Ficoxil is available in two strengths, 57 mg and 227 mg in packs of 30.
The tablets, which are presented in presented in a divisible and blister-perforated form, are hypoallergenic, gluten-free, and come in a beef flavour of animal-free origin.
Ficoxil is available now from all major veterinary wholesalers.
https://www.fortehealthcare.com/product/ficoxil
Unite, the largest trade union in the country, has announced that up to 17,000 members of the UK veterinary profession could become members within the next five years, following the establishment of the British Veterinary Union (BVU)The union says it will be able to give veterinary surgeons, veterinary nurses, practice managers, support staff and students in all disciplines, the additional muscle to tackle employment problems in the workplace, such as pay, contracts, bullying and professional development.Unite's General Secretary, Len McCluskey said: 'As a progressive trade union, Unite warmly welcomes BVU into the Unite family. The fact that a highly-regarded profession is looking to Unite for support in employment matters is an indication of the validity and relevance of trade unions in 2011 Britain.' Dr Shams Mir, Chairman, Professional Advisory Committee, British Veterinary Union in Unite said: 'Our biggest challenge will be to change the mindset of our profession to address the deep-trenched problems of working conditions and terms of employment for vets and nurses, and safeguarding their professional status. But, most importantly, we have to overcome the sense of fear amongst veterinary professionals in raising legitimate employment issues.''Veterinary professionals face the same problems in their working lives as any other health professionals, but never before have vets had a trade union to support and represent them. BVU in Unite is a great opportunity for the profession to develop and expand, and is a goal that many have aspired to for years. We believe that up to 17,000 veterinary professionals could join BVU in Unite in the next five years.'Dr Mir said that research has revealed that vets suffer from much higher levels of anxiety and depressive symptoms and they are five times more likely to have suicidal thoughts and four times more likely to commit suicide compared to the general UK population.
He said: 'Sadly, according to the most recent Royal College of Veterinary Surgeons' survey of the profession, nearly half of the responding vets and nurses said that if they had their time again, they would choose a different profession.' 'This is a wake-up call for our profession and we must act to address all the underlying problems leading to this situation.'
Further information is available at: www.bvu.org.uk and www.unitetheunion.org/bvu
Sporimune is the first ciclosporin oral solution to be licensed for use in both cats and dogs.
In cats with allergic dermatitis, ciclosporin has proved to be an effective alternative to prednisolone1 Dechra says it has a long-term safety record for chronic treatment of canine atopic dermatitis and remains one of the most important tools within a multi-modal strategy.
Sporimune is available with two dosing syringes per bottle – one for cats and one for dogs – that are graduated in body weight and ml.
There are three bottle sizes to allow for flexibility in dispensing and broached bottles last six months.
Dechra Brand Manager Claire Morgan said: "We are delighted to be able to introduce this popular and effective treatment for cats.
"Allergic skin disease can be challenging to diagnose and manage effectively for both owners and vets, with around 20 per cent of all small animal consultations involving skin conditions.
"Sporimune is a key component of a multi-modal approach involving guidance on allergen and flare factor avoidance and improving skin and coat hygiene to minimise clinical signs and the effects on quality of life for both animal and owner."
Reference
Speaking at the MSD Animal Health sponsored National Mastitis Panel, David said that more widespread understanding of the issues is urgently required particularly amongst farmers and cattle vets if real progress is to be made.
David said: "There are some notable examples of veterinary practices that have worked with their clients to eliminate the use of CIAs. These are the exceptions, but they illustrate what is possible. As an industry, we need to speed up the rate of change and make a concerted effort to ensure more responsible use of antibiotics becomes the norm, sooner rather than later."
David quoted the British Cattle Veterinary Association (BCVA) position on the responsible use of medicines, which includes the recommendation of minimal use of third and fourth generation cephalosporins, fluoroquinalones and colistin, with these CIAs being limited to use where it has been demonstrated by sensitivity testing that they are the only suitable option to avoid unnecessary suffering.
"There has been agreement on this position amongst the veterinary associations, farmer organisations and milk buyers, but there needs to be more widespread awareness at producer level, particularly within the vet and farmer relationship.
"Farms with a robust herd health plan, where challenges are reduced, will be in the best position to minimise use of CIAs. This takes time and is most effective where there is good cooperation between the farm and its veterinary practice.
"Achieving a significant reduction in the use of CIAs voluntarily will not only minimise the likelihood of disruptive and potentially punitive legislation but will put our cattle industry on the front foot and strengthen its position in global markets."
Woodley Equipment has launched the g-Pet species-specific glucose meter with a special introductory price of £9.50
Woodley says the g-Pet Glucometer makes testing quick easy and economical. Just insert a test strip, apply blood, and get results in 10 seconds.
The company highlights the following features of the new system:
Normal RRP is £49.50. Special introductory offer price is £9.50 for the next four weeks. Price includes meter, lancet, tips, 10 strips, manual, case and control solution.
For further information, or to organise a no-obligation in-practice demo, telephone 01204 669033 (option 1), or email: sales@woodleyequipment.com
Alternatively, visit www.woodleyequipment.com
York-based Alstoe Animal Health, maker of Gleptosil and Vetergesic, has been acquired by French company Sogeval, a leading supplier of companion and livestock animal products.
Established in 1994, Alstoe was privatelv owned by the two original partners, John Nellis and lan Ryder.
For the last five years the company has been working with Sogeval to develop flavoured tablet pharmaceutical brands from Sogeval whilst the two companies have collaborated to make Vetergesic successful in France.
The business will continue to trade from the current premises for the foreseeable future and says it will maintain its high standard of customer service and product supply.
John Nellis said: "lt will be business as usual. We look forward to continued sales growth for our existing brands and the introduction of exciting new products in the future".
Dr. lan Ryder said: "Our companies have worked very well together in the past. The acquisition will bring fresh impetus to the business and ensure continued growth"
The current Alstoe team remains in place to assist with any enquiries. For further information contact info@alstoe.co.uk or telephone: 01347 878605
SureFlap, a microchip pet product company, will be launching SureFeed, a new automatic cat feeder at the London Vet Show, Stand L32, on the 21st - 22nd November 2013.
The company, which already sells a range of microchip-operated pet doors, says the new products are designed to keep food fresh and the kitchen free of smells and flies.
SureFeed will be available in two models: the SureFeed Pet Feeder, which opens when any pet approaches, and the SureFeed Microchip Pet Feeder which in addition functions as a selective pet feeder that opens only when it identifies a cat with a registered microchip or RFID collar tag.
Both products feature a bowl which seals shut to keep wet food fresh.
Dr Nick Hill, inventor of SureFeed as well as founder and inventor of SureFlap says this is an exciting new development for the company: "Many cats are fussy eaters and prefer to eat food when it is fresh, others are on special diets and this can be a problem in multi-pet households. Even in households where each cat is on the same diet, a 'greedy' cat, or even dog, can eat most of the food. This can result in one pet becoming overweight while the other starts to lose condition. The SureFeed product range has been designed to address all these issues."
The SureFeed Microchip Pet Feeder recognises a cat's unique microchip number and when an authorised cat is present, the sealed lid over the bowl slides back to reveal the food. Once the cat has left the feeder, the lid slides back over the bowl. The SureFeed Pet Feeder features the same sealed lid which is triggered to open by any approaching pet, closing again when the pet has finished feeding.
Nick said: "The SureFeed product range is the culmination of two years' intensive development work. The feeders incorporate a number of features to maximise usability, such as the Microchip Pet Feeder's side guards and lid which folds up to the rear, which shield the food from other pets while the authorised cat is eating. The feeders are both easy to wipe clean and the food bowl, mat and lid can be removed and are dishwasher-safe.
"The SureFeed Pet Feeder and Microchip Pet Feeder are the first in a suite of pet feeding products from SureFlap incorporating sealed operation and flexible feeding options and we are looking forward to developing the range in the future."
SureFeed products will be available to order from early 2014 but in the meantime, you can see them in action at Stand L32 at the London Vet Show.
BSAVA Summit will take place from 16-17 December 2019 at the Royal College of Physicians in London and will involve a series of high-profile keynote speakers and interactive workshops.
The Association says the event will deliver CPD differently to other veterinary meetings, with most sessions run as facilitated workshops to enable delegates to lead and shape discussions.
Confirmed facilitators include RCVS CEO Lizzie Lockett, BEVA President Renate Weller, Director of Clinical Research and Excellence in Practice at VetPartners Rachel Dean and Small Animal Medicine Specialist and Advanced Practitioner in Veterinary Cardiology Dr Kit Sturgess. Each day delegates can choose three out of a total of five workshops. Online forums will be used in the run up to BSAVA Summit to develop ideas and thinking for the workshops before the event.
Day one will focus on ‘The Profession Today’ and topics will include workforce issues, telemedicine, specialism, the future of advanced practitioners and regulation of the profession.
Day two will explore the future of ‘The Profession Tomorrow’ with topics including communication, over-diagnosis, over-treatment and innovation.
On the Monday evening delegates, speakers and facilitators will be able to network at a drinks reception in the library at the Royal College of Physicians.
BSAVA President Sue Paterson said: "We have launched BSAVA Summit to address the rising demand for a space to debate important topics, challenge mindsets and question accepted benchmarks. Following feedback from our members and the profession, Summit will revolutionise veterinary conference norms with a free-flow approach to champion active debate, discussion and reflection.
"There is a growing need to tackle some of the ethical and professional problems that face vets today such as over diagnosis, the role of specialists in practice, and research in practice. Importantly, the format of the discussion forums means that whilst the debate is led by a facilitator, the delegates will drive the agenda to arrive at stimulating and satisfying outcomes. It has been designed to fit with the new outcomes-based approach proposed by the RCVS where veterinary professionals are encouraged to plan their CPD, do their CPD and reflect on what they have learnt.
"The delegates are the key to the event, and Summit should attract people who want to be involved, want to input, want to make a difference and want to help drive the profession forward. I already have people eagerly emailing me wanting news of when the registration goes live.
"Summit aims to help delegates take a hard look at the way they work. Our aim is for each delegate to set themselves personal goals and we will be following up in 3 months to see if they have achieved them."
The BSAVA says that although the Summit is primarily targeted at experienced small animal practitioners, all vets, including equine and large animal practitioners, are welcome to attend.
The full programme will be available and registration will open online on 17th June. BSAVA members will have an opportunity to book advance tickets, with general sale opening two weeks later.
For further information visit www.bsavasummit.com.
Entitled ‘Managing mitral valve disease from start to finish’, the course will account for four hours’ CPD split into six short bite-size sessions which can be completed at your own pace.
The sessions are presented by Dr Mike Martin MVB DVC MRCVS, and business thought leader, Dr Alison Lambert BVSc CMRS MRCVS. They consist of a practical review of MVD both pre-clinically and clinically and how to diagnose and stage it following the new 2019 American College of Veterinary Internal Medicine (ACVIM) Consensus guidelines.
The course also includes tips on how to treat and manage dogs with MVD with diuretic management; a step-by-step guide to treatment options for acute and long-term management of congestive heart failure and how to troubleshoot problem congestive heart failure cases.
There's also a bonus ‘Communicating Cardiology’ session which looks at how to communicate the heart disease journey to owners.
To register for the course visit www.veterinarywebinars.com/mvd-reg.
Ceva will donate £2 for every veterinary professional completing the course throughout February and March 2021 to Vetlife, which provides support to the veterinary community and their families who have emotional, health or financial concerns.
Eurovet Animal Health has launched Marbiflox 10%, a new marbofloxacin preparation for the treatment of respiratory infections in cattle and pigs.
Eurovet says the product can be used flexibly to provide a single dose treatment, with a concentration-dependent effect and a relatively short withdrawal period. Marbiflox can be administered intravenously, subcutaneously or intramuscularly in cattle or intramuscularly in pigs.
The main indications, with reference to good prescribing practice, are for the treatment of respiratory infections caused by sensitive strains of Pasteurella multocida, Mannheimia haemolytica, and Histophilus somni and acute forms of mastitis induced by marbofloxacin-sensitive Escherichia coli strains, during lactation. In pigs the main indication is in the treatment of MMA (metritis mastitis agalactia syndrome).
Further information about Marbiflox and the complete Eurovet range of products is available from Eurovet Animal Health. www.eurovet-ah.co.uk/.
BCF, Instrumentation Concept and VetSonic have collected 'VetSurgeon.org Best Stand Awards'; the first two at BEVA Congress and the latter at BCVA Congress.
Judging for the BEVA Congress awards was undertaken by members of BEVA Council. BCF picked up the Best Large Stand Award which was presented by outgoing President, Andrew Harrison.
Pictured left to right: BEVA President, Andrew Harrison, Gavin Mitchell and Carole Irvine of BCF, and John Alborough representing VetSurgeon.org.
Instrumentation Concept picked up the Best Shell Scheme Award
Pictured left to right: Outgoing BEVA President, Andrew Harrison; Tahir Afzac of Instrumentation Concept; John Alborough representing VetSurgeon.org, and Sheraz Ishaque of Instrumentation Concepts
At BCVA Congress, Vetsonic won the Best Stand Award.
Pictured left to right: Clare Walsh, Vetsonic Director; John Alborough, All Round Good Egg representing VetSurgeon.org; Gareth Hateley, then President BCVA and Sarah Vermont, Marketing Manager Vetsonic.
The College highlights the following key changes:
The RCVS says the new corporate look is designed to be fresh, uncluttered and professional, and the new RCVS logo and strapline - "setting veterinary standards" - should leave visitors in no doubt as to the key purpose of the RCVS as a regulatory body. And whilst the new identity is modern in feel, the use of a shield device aims to maintain the link with the College's long history.
According to the College, the new brand was described by the veterinary surgeons and veterinary nurses who helped to develop it as "simple, clear and clean, with a strong message" and "modern and approachable".
President Peter Jinman said: "The College has been accused of being 'confused and confusing' in the past. With the new identity we have endeavoured to clarify that the College is a forward-thinking regulator - despite being established when Queen Victoria was only recently on the throne, and working to 45-year-old legislation.
"Changing the logo, font and colours we use is only a small part of the process though. Our branding review included several layers of research and we now have a better understanding of how we have been perceived, how we would like to be perceived, and what we need to do to get there. This includes changing how we behave and communicate as an organisation, as well as how we position ourselves to the outside world."
The new look, which includes new logos for RCVS Awards, the RCVS Charitable Trust and the Practice Standards Scheme, will be rolled out across other communications elements as the year unfolds, to avoid the unnecessary wastage of materials branded with the old identity.
Meanwhile, the website is a living medium, and the College says it is keen to hear feedback from users about what they like, and what could be improved, to help inform further developments.
Petplan has launched a new look policy range to give pet owners more comprehensive cover and make it easier for them to understand the types of cover available.
Simon Masding, Petplan's Head of Sales and Partnerships said the refreshed policies will not only benefit the pet and their owner but the changes will also allow veterinary staff to explain the policies with a lot more clarity: "Since Petplan started 35 years ago the pet insurance market and vet industry has changed significantly, especially in the last few years. There are now over 250 policies in the market with varying benefits and levels of cover, which often confuses customers to a point where they think they're getting lifetime cover but they're instead trapped with a restrictive policy.
"The veterinary industry is also continually changing with advances in new technology and better diagnostics allowing the industry to save and treat more pets, which means our policies need to evolve with them."
To better understand these changing market dynamics, Petplan held focus groups with veterinary staff from across the UK and undertook extensive research with charities, breeders, customers and non-customers.
Apparently, the feedback showed that Petplan needed to communicate its range of policies more clearly, to shift away from the confusion created by other brands and meet the changing demands of the vet industry and pet owners better.
For this reason, Petplan says it has simplified its policy range, adding and increasing each policy's benefits, making a 12 month policy available for practices to offer, and developing easy-to-understand policy names.
Petplan's new look policies for both cats and dogs are:
Petplan says its Covered for Life policies, Petplan Ultimate and Petplan Classic, will continue to provide pet owners with the best cover in the market. However, the company recognises that these policies are not always suitable for people with older pets or a limited budget.
Simon said: "Petplan Essential, our 12 month policy, will also now be available for veterinary staff to offer to their customers. While our Covered for Life Ultimate and Classic will continue to be our leading policies and at the heart of what we do, it's better that a pet owner has some type of cover rather than nothing at all and Essential is a market leading 12 month policy."
Zeta Frasca, practice owner and vet at Kitten to Cat in Richmond London said: "These changes will not only make it clearer for the pet owner but it will also make it a lot easier for us as an industry to explain pet insurance to our clients, which is really important."
For more information about Petplan's new look policies visit www.petplan.co.uk, call their dedicated Vetline on 0800 3168 8900 or talk to your Petplan Business Developer.
The following table outlines each policy and its benefits:
Zoetis has launched Suvaxyn Parvo/E, a combined vaccine which it says provides the earliest protection of gilts against parvovirus and erysipelas.
Parvovirus and erysipelas infections occur primarily in gilts and sows, negatively impacting their reproductive success and the health of their litters - inevitably reducing profitability.
Nigel Lodge, National Veterinary Manager for Zoetis, said: "The combined vaccine will help ensure the health of gilts and sows is not affected by these two infections which are widespread in the pig herd.
"Suvaxyn® Parvo/E gives the earliest protection so that the ability to vaccinate gilts at five months of age will help ensure a good start to their reproductive life. Up to half of all pigs may be carriers of erysipelas and importantly the vaccine has licensed efficacy against both Erysipelothrix serotypes 1 and 2.
"This brings another vaccine to our portfolio, making it one of the largest in the pig sector and confirming the ongoing commitment of Zoetis to the health and welfare of pigs."
Suvaxyn® Parvo/E is an inactivated combination vaccine approved for immunising gilts and sows to prevent reproductive disorders caused by porcine parvovirus and reduce clinical signs caused by Erysipelothrix rhusiopathiae.
Primary vaccination is recommended from five months of age, with two injections given three to four weeks apart, ensuring the second dose occurs at least four weeks before mating. Revaccination should take place three to four weeks before each subsequent mating.
The vaccine comes in 10-dose and 2 X 25-dose packs. For more information, contact your Zoetis Pig Key Account Manager.
Vets Now launched the service at the start of the pandemic to provide remote veterinary advice, and it has now expanded from eight to nearly 30 emergency vets.
In 2022, Video Vets Now had over 13,000 consultations, with 80% of these occurring out-of-hours. Sundays are the busiest day, with almost a third of all consultations taking place.
Of these total consultations, 17% of pets were discharged normally, 7% were immediately referred in-clinic, and 48% were discharged as non-emergency cases, but with a recommendation to get a daytime vet appointment within 48 hours.
Dave Leicester, Vets Now’s head of telehealth says the fact that so few of Video Vets Now calls are referred on to a face-to-face consultation is a real benefit for pet owners and the veterinary profession: “Over two thirds of cases don’t need to be seen urgently by a vet.
"A lot of the cases are pet owners needing some clinical reassurance.
"As cases are triaged remotely, the service therefore frees up clinical staff for genuine emergencies.
“Additionally, without the service, many clients would have no other option than to attend for a full consultation at an out-of-hours clinic; so, clients save money too, allowing them to save their budget to spend at their daytime practices.
“Following the triage consultation, if the pet does need a non-urgent face-to-face consultation, we always direct clients to their registered vet. The £24 Video Vets Now consultation fee is then refunded.
"We call this our ‘Never Pay Twice’ promise, and it applies regardless of where that follow on consultation takes place.
"We see this as a win-win situation for clients and practices.”
Dave continued: “Over the past three years, Video Vets Now has seen unparalleled growth, providing essential care and reassurance for pet owners during a time of many challenges to traditional veterinary practice.
“As the pandemic has drawn to a close, we have consolidated our position as one of the UK's foremost providers of teletriage.
"Looking to the future, the changes in veterinary regulation will allow us to grow further and expand the range of services we can provide, bringing telehealth to an even greater number of pet owners.”
Invicta Animal Health has announced its appointment as exclusive veterinary distributor in the UK for Chloraprep, a licensed human product for cutaneous antisepsis, prior to invasive procedures.
Invicta says Chloraprep is a single use, easy to apply, sterile system, available in a variety of sizes and in clear and tinted versions to enhance the visibility of the area requiring antisepsis, for instance, prior to surgery.
The sterile solution is maintained in a glass ampoule inside a protective outer case and, to prevent contamination, the patented design ensures users don't come into contact with either the contents or the patient's skin.
Rob Watkins, Managing Director of Invicta, said: "Most surgical site infections (SSI's) are the result of contamination from a patient's own skin flora1, a fact which highlights the importance of thorough and effective preparation of the skin as a proactive way to minimise the incidence of SSI's in patients."
According to the company, research has shown that Chloraprep, which contains 2% chlorhexidine and 70% isopropyl alcohol, has demonstrated significantly better antimicrobial activity than other combinations2.
Invicta says the way in which the solution is applied to the skin is as important as the solution itself. Studies show that the most effective way to apply Chloraprep is with a back and forth scrubbing movement because this gives a lower microbial count on the skin than using other application methods3. Once applied, Chloraprep is active in 30 seconds and is effective for up to 48 hours4.
Rob said: "The majority of UK hospitals and the Blood Transfusion Service already use Chloraprep and we are pleased to make this available under the provisions of the cascade."
He added: 'The veterinary nurses I've spoken to love this product, because they're fed up of immersing their dry, cracked hands in disinfectant!'
For further information, please contact Invicta Animal Health on 01403 791313 or email the company at mail@invictavet.com.
References
1. Florman S, Nichols RL. Am J Infect Dis 2007; 3: 51-61.2. Hibbard JS. J Infus Nurs 2005; 28: 194-207.3. Rosenthal K. Nurs Manage 2006; April: 55-66.4. Garcia R et al. Abstracts of the IDSA 40th Annual Meeting 2002; Abs 418.
The intranasal vaccine can be administered to calves from one week old. It reduces the clinical signs of respiratory disease and viral shedding from infection with Bovine Respiratory Syncytial Virus (BRSV) and Parainfluenza-3 Virus (Pi3V).
MSD says that no other UK-licensed BRD vaccine can be administered earlier in life, and claims the vaccine delivers the fastest on-farm protection, with an onset of immunity after administration of 5 days for BRSV and 7 days for Pi3V. Duration of immunity is 12 weeks for both viruses.
MSD Animal Health livestock veterinary adviser Dr Kat Baxter-Smith said: "Having this early life calf pneumonia vaccine available in single dose vials will give farmers more practical leeway to be able to vaccinate vulnerable young calves from as young as a week of age, rather than delaying administration until a batch of calves are available. We know that early-age protection of young calves through intranasal vaccination can help prevent pneumonia and positively impact a beef or dairy calf’s productive future".
The new single dose vials are supplied in packs of five, complementing the five dose vials already available.
For further information, contact your MSD account manager.
Kaminox contains potassium gluconate and B-vitamins to help dogs affected by hypokalaemia.
Originally released as an oral liquid supplement, Vetplus says this new powdered formulation offers a more concentrated level of potassium for larger pets or those that require a higher dose.
Kaminox sachets are sold in packs of 30, with a scoop provided for easy administration.
Meanwhile, the liquid supplement is available in 60ml and 120ml bottles.
www.vetplus.co.uk/products